Phase II trial of combined irinotecan and oxaliplatin given every 3 weeks to patients with metastatic colorectal cancer.

Hoff, Paulo M; Wolff, Robert A; Xiong, Henry; Jones, Dennie; Lin, Edward; Eng, Cathy; Dutta, Ankhi; Bogaard, Karla R; Abbruzzese, James L

Hoff, Paulo M; Wolff, Robert A; Xiong, Henry; Jones, Dennie; Lin, Edward; Eng, Cathy; Dutta, Ankhi; Bogaard, Karla R; Abbruzzese, James L.

Affiliation

Hoff PM; Department of Gastrointestinal Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. hoffpaulo@yahoo.com

Cancer ; 106(10): 2241-6, 2006 May 15.

Article in En | MEDLINE | ID: mdl-16598762

Subject(s)

Adenocarcinoma/drug therapy; Adenocarcinoma/secondary; Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Colorectal Neoplasms/drug therapy; Adenocarcinoma/mortality; Adult; Aged; Camptothecin/administration & dosage; Camptothecin/analogs & derivatives; Colorectal Neoplasms/mortality; Colorectal Neoplasms/pathology; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Irinotecan; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Organoplatinum Compounds/administration & dosage; Oxaliplatin; Risk Assessment; Single-Blind Method; Survival Analysis; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Year: 2006 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links